Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatric Neurology · Childhood-onset stress-induced neurodegeneration with ataxia and seizures

Supportive Care and Daily Management for CONDSIAS

At a Glance

There is no proven cure for CONDSIAS, so care focuses on responding quickly to illness and seizures, maintaining hydration and nutrition, protecting swallowing safety, and supporting movement through physical and occupational therapy.

Managing CONDSIAS (Stress-induced childhood-onset neurodegeneration with ataxia and seizures) is currently centered on supportive care. This means that while there is no cure or proven treatment to “fix” the underlying genetic change in the ADPRHL2 gene, doctors focus on protecting your child’s health, managing symptoms, and responding quickly to triggers [1][2].

The Standard of Care: Proactive Support

Because the hallmark of CONDSIAS is a stepwise decline often reported in association with stress, “standard care” focuses on keeping the body as stable as possible [3].

1. Individualized Sick-Day Management

Infection and fever are frequently reported triggers for a neurological “step” or regression [4].

  • Reactive Care: Discuss with your doctor a threshold for treating fevers. This often means using fever-reducing medications (antipyretics) like acetaminophen or ibuprofen to manage discomfort and temperature, according to an individualized written sick-day plan [3]. Avoid starting or changing these medicines solely from internet guides, as incorrect dosing or using ibuprofen during dehydration can be unsafe.
  • Illness Protocol: During an infection, it is vital to ensure your child stays hydrated and nourished, as poor intake can further stress their cells [3].

2. Seizure Management

Seizures in CONDSIAS can range from infrequent “staring spells” to severe convulsions [5][6].

  • Seizure Action Plan: You should have a written plan from your neurologist and ask if your child needs prescribed “rescue medications” to stop a seizure if it lasts too long [5]. Never give unprescribed medication.
  • Standard Medications: There is no “perfect” seizure drug for CONDSIAS; doctors typically use standard pediatric epilepsy medications based on your child’s specific seizure type [6].

3. Nutritional and GI Support

Some children with CONDSIAS experience gastrointestinal intolerance, which can look like abdominal distension (bloating), poor appetite, or difficulty digesting food [7][6].

  • Dietary Monitoring: A nutritionist can help ensure your child is getting enough calories to support their brain health, especially during periods of stress [3].
  • Swallowing Safety: Because ataxia can affect the muscles used for swallowing, regular checks for aspiration risk (food going into the lungs) are important when symptoms suggest an issue [8].

Experimental Treatments: What the Evidence Says

You may hear about experimental treatments in research papers or online communities. It is important to distinguish between “preclinical” research (in labs) or isolated case reports and “standard” care for children.

  • High-Dose Vitamins: There are very early case reports of some children showing “favorable responses” to high-dose vitamin supplementation (such as B3/nicotinamide, B2/riboflavin, or CoQ10) [3]. However, these are individual observations and have not yet been proven in large clinical trials. High doses can cause severe toxicity and should only be used under the strict guidance of a metabolic specialist [3].
  • Minocycline: While once thought to be a potential treatment based on animal models, more recent cell studies found that minocycline was ineffective at reducing the toxic buildup (ADP-ribosylation) caused by ADPRHL2 mutations [9]. It is not considered a standard or proven treatment [10].
  • PARP Inhibitors (e.g., Olaparib): These drugs are being studied because they block the enzyme (PARP1) that creates the toxic “tags” in the cells [11]. While they have shown promise in laboratory cells and mice, they have not been approved for use in children with CONDSIAS and carry significant risks that must be managed by experts [11][12].

Living with Ataxia and Regression

Daily management also involves supporting your child’s physical abilities.

  • Rehabilitation: Regular Physical Therapy (PT) and Occupational Therapy (OT) are essential to provide safe mobility guidance and adapt to any loss of skills [1].
  • Activity Planning: While extreme physical exhaustion is anecdotally cited as a trigger, it is important to encourage safe, paced activity rather than restricting normal play out of fear [3].
  • Emotional Stability: While severe emotional distress is reported as a potential trigger, everyday emotions are normal. Focus on providing emotional support for the whole family rather than trying to avoid all emotional stress, which can cause unnecessary caregiver guilt [3][13].

By focusing on these daily measures, you are not just managing a condition; you are actively working to protect your child’s stability and quality of life [1].

Common questions in this guide

What is the usual care for a child with CONDSIAS?
Care for CONDSIAS is mainly supportive because there is no cure or proven treatment that reverses the underlying genetic change. The care team focuses on responding to illness, managing seizures, maintaining hydration and nutrition, checking swallowing safety, and supporting mobility and daily function.
What should I do if my child with CONDSIAS develops a fever or infection?
Ask the treating team for a written sick-day plan before an illness occurs. It should explain when to treat fever, how to use weight-based fever medicine, and how to maintain fluids and nutrition. Do not change medication doses on your own, and ask before using ibuprofen if your child may be dehydrated.
How are seizures managed in children with CONDSIAS?
A neurologist usually selects a standard pediatric antiseizure medicine based on the child's seizure type and creates a written seizure action plan. Some children may also need a prescribed rescue medicine for a seizure that lasts too long or meets other criteria in the plan. Never give an unprescribed seizure medicine.
Are high-dose vitamins, minocycline, or PARP inhibitors proven treatments for CONDSIAS?
No. High-dose vitamins have only been described in early individual reports and can cause serious toxicity, while minocycline is not a proven standard treatment. PARP inhibitors have shown promise in laboratory studies but are not approved for children with CONDSIAS, so these approaches should only be discussed with the appropriate specialists.
When might a child with CONDSIAS need nutrition or swallowing support?
A nutrition assessment may help when a child has poor appetite, bloating, gastrointestinal intolerance, or difficulty maintaining food and fluid intake. A swallowing assessment may be needed when ataxia affects swallowing or there are signs that food or liquid could enter the lungs. The care team can recommend the appropriate evaluation and support.
What therapies and activities can help a child with CONDSIAS?
Physical and occupational therapy can promote safer movement and help adapt to changes in skills. Activity is usually best kept safe and paced rather than stopped completely because of fear of exhaustion; normal play can be encouraged as tolerated. Emotional support for the child and family is also an important part of daily care.

Get notified when new evidence is published on Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    CONDSIAS, a Stress-Triggered Childhood Neurodegeneration: Four Novel ADPRS Variants and a Structured Review of the Reported Phenotype.

    Comisi FF, Staccioli S, Travaglini L, et al.

    Cerebellum (London, England) 2026; (25(6)).

    PMID: 42986566
  2. 2

    An ADPRS variant disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure.

    Bannister M, Bray S, Aggarwal A, et al.

    HGG advances 2025; (6(1)):100386 doi:10.1016/j.xhgg.2024.100386.

    PMID: 39580621
  3. 3

    Phenotypic Diversity in Stress-induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures: Novel Associations with Parkinsonism, Icthyosis and Cataract.

    Nandana J, Fasaludeen A, Kumar AA, et al.

    Cerebellum (London, England) 2025; (24(4)):112 doi:10.1007/s12311-025-01866-3.

    PMID: 40493129
  4. 4

    Delineation of ADPRHL2 Variants: Report of Two New Patients with Review of the Literature.

    Öz Yıldız S, Yalnızoğlu D, Şimsek Kiper PÖ, et al.

    Neuropediatrics 2024; (55(3)):156-165 doi:10.1055/s-0044-1779618.

    PMID: 38365196
  5. 5

    Child-Onset Cerebellar Ataxia Caused by Two Compound Heterozygous Variants in ADPRS Gene: A Case Report.

    Ma J, Qian Q, Yan S, et al.

    Frontiers in genetics 2021; (12()):788702 doi:10.3389/fgene.2021.788702.

    PMID: 35664652
  6. 6

    Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report.

    Aryan H, Razmara E, Farhud D, et al.

    BMC neurology 2020; (20(1)):291 doi:10.1186/s12883-020-01873-3.

    PMID: 32746785
  7. 7

    Case Report: Stress-Induced Childhood-Onset Neurodegeneration With Ataxia-Seizures Syndrome Caused by a Novel Compound Heterozygous Mutation in ADPRHL2.

    Lu A, Dong C, Chen B, et al.

    Frontiers in neurology 2022; (13()):807291 doi:10.3389/fneur.2022.807291.

    PMID: 35222245
  8. 8

    Unveiled central hypoventilation after tracheotomy in anti-IgLON5 disease: a case report.

    Tankéré P, Le Cam P, Folliet L, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2023; (19(9)):1701-1704 doi:10.5664/jcsm.10658.

    PMID: 37166031
  9. 9

    Novel ADPRS Missense Variant (p.Leu162Pro) Causes Stress-Induced Childhood-Onset Neurodegeneration With Ataxia and Seizures.

    de Mattos PD, de Moura RD, Bertolino MF, et al.

    Neurology. Genetics 2026; (12(3)):e200375 doi:10.1212/NXG.0000000000200375.

    PMID: 42015965
  10. 10

    Expanding the Spectrum of Stress-Induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures (CONDSIAS).

    Lindskov FO, Karlsson WK, Skovbølling SL, et al.

    Cerebellum (London, England) 2024; (23(2)):861-871 doi:10.1007/s12311-023-01582-w.

    PMID: 37392332
  11. 11

    A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 ( Arh3 ) deficiency.

    Yamashita S, Bu X, Ishiwata-Endo H, et al.

    bioRxiv : the preprint server for biology 2023; doi:10.1101/2023.02.07.527369.

    PMID: 36945462
  12. 12

    Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response.

    Beijer D, Agnew T, Rack JGM, et al.

    Life science alliance 2021; (4(11)) doi:10.26508/lsa.202101057.

    PMID: 34479984
  13. 13

    [Multidisciplinary care and therapeutic advances in amyotrophic lateral sclerosis].

    Matamala JM, Moreno-Roco J, Acosta I, et al.

    Revista medica de Chile 2022; (150(12)):1633-1646 doi:10.4067/s0034-98872022001201633.

    PMID: 37906785

This page describes supportive care for children with CONDSIAS for educational purposes only and does not replace medical advice. A pediatric neurologist and the child's care team should create individualized fever, seizure, nutrition, and medication plans.